The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks long-term capital appreciation.
The fund invests a majority of its assets in a diversified portfolio of equity securities of large foreign companies that the portfolio managers believe are undervalued. Under normal conditions, it invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities. A large company is defined as a company included among the largest 80% of companies in terms of market capitalization at the time of investment in the MSCI ACWI ex USA® Index.
The average market capitalization across the Lord Abbett International Equity P MF is 158.37B. The market cap for tickers in the group ranges from 7.55B to 271.34B. ASML holds the highest valuation in this group at 271.34B. The lowest valued company is NOV at 7.55B.
The average weekly volume growth across all stocks in the Lord Abbett International Equity P MF was 164%. For the same stocks of the MF, the average monthly volume growth was 11% and the average quarterly volume growth was -11%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 51
P/E Growth Rating: 48
Price Growth Rating: 49
SMR Rating: 63
Profit Risk Rating: 42
Seasonality Score: 27 (-100 ... +100)